Results 11 to 20 of about 6,781,998 (147)

Anti-carbamylated protein antibodies and skin involvement in patients with systemic sclerosis: An intriguing association. [PDF]

open access: yesPLoS ONE, 2018
Carbamylation is a post-translational modification that mostly affects proteins with low turnover, such as dermal proteins. Carbamylated proteins accumulate in skin in an age-dependent manner, contributing to tissue alterations.
Elvira Favoino   +6 more
doaj   +3 more sources

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients [PDF]

open access: yesScientific Reports, 2017
Classification of patients with rheumatoid arthritis (RA) as quickly as possible improves their prognosis. This reason motivates specially dedicated early arthritis (EA) clinics.
Cristina Regueiro   +9 more
doaj   +4 more sources

Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis [PDF]

open access: yesArthritis Research & Therapy, 2017
Background Rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and anti-carbamylated protein (anti-CarP) antibodies are rheumatoid arthritis (RA)-associated autoantibodies. Besides their presence in human serum, anti-CarP antibodies have
Marije K. Verheul   +4 more
doaj   +4 more sources

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients [PDF]

open access: yesArthritis Research & Therapy, 2017
Background Anti-carbamylated protein (anti-CarP) antibodies have recently been reported to occur in around 45% of rheumatoid arthritis (RA) patients and to have prognostic and diagnostic properties.
Myrthe A. M. van Delft   +8 more
doaj   +3 more sources

Anti‐Modified Protein Antibodies in Rheumatoid Arthritis: Pathogenic, Protective, or Passive Bystander? [PDF]

open access: yesImmunological Reviews, Volume 341, Issue 1, August 2026.
ABSTRACT The presence of anti‐modified protein antibodies (AMPA) is a hallmark of rheumatoid arthritis (RA). AMPA recognize post‐translationally modified proteins and are cross‐reactive. AMPA include anti‐citrullinated protein antibodies (ACPA), anti‐carbamylated protein antibodies (anti‐CarP), and anti‐acetylated protein antibodies (AAPA).
Amber‐Sarai F. L. Stalman   +1 more
wiley   +3 more sources

Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis

open access: yesImmunological Medicine, 2019
Several autoantibodies against proteins with post-translational modifications have been detected in patients with rheumatoid arthritis (RA) and are called anti-modified protein antibodies (AMPAs).
Shuichiro Nakabo
doaj   +2 more sources

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis [PDF]

open access: yesBMC Musculoskeletal Disorders, 2022
Objective Rheumatoid arthritis (RA) is often complicated with chronic lung diseases (CLD), including interstitial lung disease (ILD) and airway disease, which occur as extra-articular manifestations.
Shomi Oka   +13 more
doaj   +2 more sources

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies [PDF]

open access: yesScientific Reports, 2021
The initial management of rheumatoid arthritis (RA) has a high impact on disease prognosis. Therefore, we need to select the most appropriate treatment as soon as possible. This goal requires biomarkers of disease severity and prognosis.
Cristina Regueiro   +10 more
doaj   +2 more sources

Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis

open access: yesIndian Journal of Rheumatology, 2019
Background: Anti-carbamylated protein (anti-CarP) antibodies are present in patients with Rheumatoid arthritis (RA) and may present before disease onset.
Ashraf H Mohamed   +6 more
doaj   +2 more sources

Anti‐Carbamylated Protein Antibodies Stabilize Carbamylated Histone H3 to Promote Synovial Activation and Neutrophil Extracellular Trap‐Mediated Bone Loss in Rheumatoid Arthritis [PDF]

open access: yesArthritis &Rheumatology, Volume 78, Issue 10, Page 2074-2081, October 2026.
Objective Carbamylation, a nonenzymatic post‐translational modification, contributes to rheumatoid arthritis (RA) pathogenesis. Anti‐carbamylated protein antibodies (anti‐CarP) occur in around 50% of patients with RA and associate with greater joint damage. Neutrophil extracellular traps (NETs) are a major source of carbamylated autoantigens. We sought
Shuichiro Nakabo   +9 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy